Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients

Oncology Reports

Volumn 27, Issue 2, 2012, Pages 376-382

  Shen, Yang Mei ^a,b   Arbman, Gunnar ^c   Sandström, Per ^a   Gullstrand, Per ^a   Wei, Yu Quan ^d   Zhang, Hong ^e   Rosell, Johan ^a   Olsson, Birgit ^a   Peng, Feng ^d   Yang, Han Shuo ^d   Wang, Chun Ting ^d   Sun, Xiao Feng ^a,f  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SICHUAN UNIVERSITY   (China)

^c VRINNEVI HOSPITAL   (Sweden)

^d WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

^e UNIVERSITY OF SKÖVDE   (Sweden)

^f SICHUAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Human Biot2; In situ hybridization; Prognosis; Real time PCR

Indexed keywords

RNA;

ADULT; AGED; ARTICLE; BIOT2 GENE; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER STAGING; CELL NUCLEUS; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER METASTASIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; INTESTINAL MUCOSA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862919681     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1521     Document Type: Article

References (29)

1. Stewart BW and Kleihues P: World Cancer Report. World Health Organization, WHO Press, 2003.
2. Cancerfonden: Cancerfondsrapporten, 2008 (In Swedish).
3. Duffy MJ, van Dalen A, Haglund C, et al: Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Marker (EGTM) guidelines. Eur J Cancer 39: 718-727, 2003. (Pubitemid 36315986)
4. Anwar S, Frayling IM, Scott NA, et al: Systematic review of genetic influences on the prognosis of colorectal cancer. Br J Surg 91: 1275-1291, 2004. (Pubitemid 39331451)
5. Miyoshi N, Ishii H, Sekimoto M, Doki Y and Mori M: RGS16 is a marker for prognosis in colorectal cancer. Ann Surg Oncol 16: 3507-3514, 2009.
6. Chen YT, Scanlan MJ, Sahin U, et al: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918, 1997. (Pubitemid 27113936)
7. Yang H, Wang C, Wang R, et al: Characterization of a novel rat gene RTAP2a, screened by cross-reactive SEREX, restrictedly expressed in testis. J Biosci Bioeng 107: 589-595, 2009.
8. Wang Ct, Zhang P, Wang YS, et al: RNA interference against Biot2, a novel mouse testis-specific gene, inhibits the growth of tumor cells. Cell Mol Biol Lett 14: 363-376, 2009.
9. Yangmei S, Xiang H, Hongxin D, et al: Expression of human Biot2 and its potential function on carcinogenesis in endometrial cancer. Acta Obstet Gynecol Scand 86: 1503-1509, 2007. (Pubitemid 350135594)
10. Pfeifer D, Gao J, Adell G and Sun XF: Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys 65: 1143-1148, 2006.
11. Zhang ZY, Zhao ZR, Adell G, et al: Expression of MAC30in rectal cancers with or without preoperative radiotherapy. Oncology 71: 259-265, 2006.
12. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM and Fidler IJ: Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48: 6863-6871, 1988. (Pubitemid 19012219)
13. Morikawa K, Walker SM, Jessup JM and Fidler IJ: In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 48: 1943-1948, 1988.
14. Murray-Zmijewski F, Lane DP and Bourdon JC: p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13: 962-972, 2006.
15. Nakamura Y, Nawata M and Wakitani S: Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am J Pathol 167: 97-105, 2005. (Pubitemid 40884774)
16. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr and Chen LB: The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 105: 820-826, 1993. (Pubitemid 23249492)
17. Petersen M, Nielsen CB, Nielsen KE, et al: The conformations of locked nucleic acids (LNA). J Mol Recognit 13: 44-53, 2003.
18. Bondensgaard K, Petersen M, Singh SK, et al: Structural studies of LNA: RNA duplexes by NMR: conformations and implications for RNase H activity. Chemistry 6: 2687-2695, 2000.
19. Petersen M, Nielsen JT, Bondensgaard K, Wengel J and Jacobsen JP: Structural characterization of LNA and alphaL-LNAhybridized to RNA. Nucleosides Nucleotides Nucleic Acids 22: 1691-1693, 2003. (Pubitemid 37139476)
20. Green DR and Evan GI: A matter of life and death. Cancer Cell 1: 19-30, 2002. (Pubitemid 41039172)
21. Chen YC, Davidson B, Cheng CC, et al: Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma. Biochim Biophys Acta 1730: 96-102, 2005. (Pubitemid 41133467)
22. Korkmaz CG, Korkmaz KS, Kurys P, et al: Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene 24: 4934-4945, 2005. (Pubitemid 41129097)
23. Simon I, Zhuo S, Corral L, et al: B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res 66: 1570-1575, 2006. (Pubitemid 43259939)
24. Katkoori VR, Jia X, Shanmugam C, et al: Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res 15: 2406-2416, 2009.
25. Pancione M, Forte N, Fucci A, et al: Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Hum Pathol 41: 867-876, 2010.
26. Bénard J, Douc-Rasy S and Ahomadegbe JC. TP53 family members and human cancers. Hum Mutat 21: 182-191, 2003. (Pubitemid 36292961)
27. Sun XF: p73 overexpression is a prognostic factor in patients 27. with colorectal adenocarcinoma. Clin Cancer Res 8: 165-170, 2002.
28. Kayed H, Kleeff J, Ding J, et al: Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract. Histol Histopathol 19: 1021-1031, 2004. (Pubitemid 39386761)
29. Moparthi SB, Arbman G, Wallin A, et al: Expression of MAC30protein is related to survival and biological variables in primary and metastatic colorectal cancers. Int J Oncol 30: 91-95, 2007.